Headlands Technologies LLC Takes $290,000 Position in Maximus, Inc. (NYSE:MMS)

Headlands Technologies LLC bought a new position in shares of Maximus, Inc. (NYSE:MMS - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 3,885 shares of the health services provider's stock, valued at approximately $290,000.

A number of other hedge funds have also recently added to or reduced their stakes in MMS. Franklin Resources Inc. boosted its position in shares of Maximus by 21.8% in the fourth quarter. Franklin Resources Inc. now owns 6,176 shares of the health services provider's stock worth $461,000 after acquiring an additional 1,104 shares during the last quarter. Meeder Asset Management Inc. acquired a new stake in shares of Maximus during the 4th quarter worth $1,407,000. Arrowstreet Capital Limited Partnership raised its position in shares of Maximus by 108.5% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 84,309 shares of the health services provider's stock worth $6,294,000 after buying an additional 43,864 shares during the period. Pictet Asset Management Holding SA boosted its holdings in Maximus by 8.6% in the fourth quarter. Pictet Asset Management Holding SA now owns 8,563 shares of the health services provider's stock valued at $639,000 after acquiring an additional 676 shares during the last quarter. Finally, New Age Alpha Advisors LLC purchased a new stake in Maximus during the fourth quarter valued at about $3,345,000. 97.21% of the stock is owned by institutional investors and hedge funds.

Maximus Stock Down 2.2 %

NYSE:MMS traded down $1.50 during mid-day trading on Thursday, hitting $66.39. The company had a trading volume of 231,875 shares, compared to its average volume of 687,406. The business has a fifty day simple moving average of $68.20 and a 200-day simple moving average of $76.49. The firm has a market capitalization of $3.76 billion, a price-to-earnings ratio of 14.24 and a beta of 0.68. Maximus, Inc. has a 1 year low of $63.77 and a 1 year high of $93.97. The company has a current ratio of 1.72, a quick ratio of 1.72 and a debt-to-equity ratio of 0.82.

Remove Ads

Maximus (NYSE:MMS - Get Free Report) last released its quarterly earnings results on Thursday, February 6th. The health services provider reported $1.61 EPS for the quarter, topping the consensus estimate of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. Equities analysts forecast that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Saturday, May 31st. Stockholders of record on Thursday, May 15th will be paid a dividend of $0.30 per share. The ex-dividend date of this dividend is Thursday, May 15th. This represents a $1.20 annualized dividend and a dividend yield of 1.81%. Maximus's dividend payout ratio is presently 25.81%.

Analysts Set New Price Targets

MMS has been the topic of several research analyst reports. Raymond James raised Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 price objective on the stock in a research note on Thursday, January 2nd. StockNews.com cut shares of Maximus from a "buy" rating to a "hold" rating in a research report on Friday, February 14th.

Insider Transactions at Maximus

In other Maximus news, insider Ilene R. Baylinson sold 14,500 shares of the firm's stock in a transaction on Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total transaction of $988,030.00. Following the completion of the transaction, the insider now directly owns 2,512 shares of the company's stock, valued at $171,167.68. This trade represents a 85.23 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Jan Madsen sold 2,439 shares of the company's stock in a transaction dated Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total transaction of $165,144.69. Following the completion of the sale, the director now owns 18,097 shares in the company, valued at approximately $1,225,347.87. This trade represents a 11.88 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.60% of the company's stock.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.